Evercore ISI Trims DENTSPLY SIRONA (NASDAQ:XRAY) Target Price to $35.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its price objective decreased by Evercore ISI from $40.00 to $35.00 in a research note released on Friday, Benzinga reports. Evercore ISI currently has an outperform rating on the medical instruments supplier’s stock.

XRAY has been the topic of a number of other research reports. Barrington Research reduced their price target on DENTSPLY SIRONA from $41.00 to $38.00 and set an outperform rating on the stock in a report on Friday. Leerink Partnrs reissued an outperform rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. Robert W. Baird dropped their price target on DENTSPLY SIRONA from $35.00 to $33.00 and set a neutral rating for the company in a research note on Friday. SVB Leerink started coverage on shares of DENTSPLY SIRONA in a report on Monday, February 26th. They issued an outperform rating and a $42.00 price target on the stock. Finally, StockNews.com upgraded shares of DENTSPLY SIRONA from a hold rating to a buy rating in a report on Friday, January 19th. Five investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of Moderate Buy and an average target price of $35.89.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY opened at $28.29 on Friday. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.95 and a current ratio of 1.43. DENTSPLY SIRONA has a fifty-two week low of $26.27 and a fifty-two week high of $41.65. The firm has a market cap of $5.87 billion, a PE ratio of -64.29, a price-to-earnings-growth ratio of 1.15 and a beta of 1.00. The business has a 50 day moving average price of $32.13 and a 200-day moving average price of $32.71.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, meeting analysts’ consensus estimates of $0.42. The company had revenue of $953.00 million during the quarter, compared to analyst estimates of $969.45 million. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The firm’s revenue was down 2.6% compared to the same quarter last year. During the same period in the prior year, the business posted $0.39 EPS. Equities research analysts predict that DENTSPLY SIRONA will post 2.04 earnings per share for the current year.

DENTSPLY SIRONA Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Friday, March 29th were given a dividend of $0.16 per share. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. This represents a $0.64 dividend on an annualized basis and a yield of 2.26%. The ex-dividend date of this dividend was Wednesday, March 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -145.45%.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Principal Securities Inc. bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth approximately $26,000. VisionPoint Advisory Group LLC raised its stake in DENTSPLY SIRONA by 104.2% during the third quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock valued at $26,000 after buying an additional 395 shares during the last quarter. Headlands Technologies LLC bought a new stake in DENTSPLY SIRONA in the fourth quarter worth $30,000. Parkside Financial Bank & Trust grew its stake in shares of DENTSPLY SIRONA by 33.3% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock worth $42,000 after acquiring an additional 292 shares during the last quarter. Finally, Anchor Investment Management LLC bought a new position in shares of DENTSPLY SIRONA during the fourth quarter valued at $47,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.